2008
DOI: 10.1136/jnnp.2007.129478
|View full text |Cite
|
Sign up to set email alerts
|

Relapsing encephalopathy in a patient with  -methylacyl-CoA racemase deficiency

Abstract: Alpha-methylacyl-CoA racemase (AMACR) deficiency is a rare disorder of fatty acid metabolism which has recently been described in three adult cases. We have identified a further patient with clinical features of a relapsing encephalopathy, seizures and cognitive decline over a 40 year period. Biochemical studies revealed grossly elevated plasma pristanic acid levels, and a deficiency of AMACR in skin fibroblasts. Sequence analysis of AMACR cDNA identified a homozygous point mutation (c154T>C). This case adds t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(20 citation statements)
references
References 9 publications
0
20
0
Order By: Relevance
“…The product of AMACR , alpha-methyl-CoA racemase, plays a pivotal role in lipid and bile acid metabolism. AMACR deficiency (MIM 604489) can lead to the toxic accumulation of metabolic intermediates in tissues and blood plasma, most notably pristanic acid via the α-oxidation pathway, characterized by adult onset of neurodegenerative symptoms, including sensory motor neuropathy, pigmentary retinopathy, seizures, and neurocognitive impairment [Thompson et al, 2007]. In one documented patient, AMACR deficiency was comorbid with schizophrenia, displaying elevated plasma pristanic acid levels and neurologic deficits resembling stroke-like episodes [Kapina et al, 2010].…”
Section: Discussionmentioning
confidence: 99%
“…The product of AMACR , alpha-methyl-CoA racemase, plays a pivotal role in lipid and bile acid metabolism. AMACR deficiency (MIM 604489) can lead to the toxic accumulation of metabolic intermediates in tissues and blood plasma, most notably pristanic acid via the α-oxidation pathway, characterized by adult onset of neurodegenerative symptoms, including sensory motor neuropathy, pigmentary retinopathy, seizures, and neurocognitive impairment [Thompson et al, 2007]. In one documented patient, AMACR deficiency was comorbid with schizophrenia, displaying elevated plasma pristanic acid levels and neurologic deficits resembling stroke-like episodes [Kapina et al, 2010].…”
Section: Discussionmentioning
confidence: 99%
“…[2][3][4][5][6] Although each patient exhibited different clinical features, neurologic symptoms including seizures, peripheral neuropathy, altered mental status, and relapsing encephalitis were common among the adults. The reason for clinical relapses is unclear, although oxidative stresses, such as minor surgeries, may precipitate the release of pristanic acid from tissue stores.…”
Section: Case Reportmentioning
confidence: 98%
“…AMACR deficiency has been described in several patients, mainly adults with a late-onset sensorimotor neuropathy, epilepsy, encephalopathy, pyramidal tract signs and migraine [4][5][6][7][8]. AMACR deficiency can also appear in the neonatal period with coagulopathy and mild cholestasis due to bile acid abnormalities [9].…”
Section: Introductionmentioning
confidence: 99%